PI
IMVT icon

Putnam Investments’s Immunovant IMVT Stock Holding History

Putnam Investments’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.23M Buy
+52,984
New +$1.95M ﹤0.01% 733
2021
Q1 		– Sell
-136,976
Closed -$6.33M – 804
2020
Q4 		$6.33M Buy
136,976
+15,200
+12% +$703K 0.01% 459
2020
Q3 		$4.29M Buy
121,776
+10,569
+10% +$318K 0.01% 511
2020
Q2 		$2.71M Buy
+111,207
New +$2.38M 0.01% 598

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Putnam Investments's IMVT Position: Q4 2023 in Review

Putnam Investments opened a new position in Immunovant (IMVT) in Q4 2023: 52,984 shares worth $2.23M. The stake represents ﹤0.01% of the portfolio and ranks #733 among its holdings. This is a return to the name: Putnam Investments previously reported a position in IMVT as recently as Q4 2020.

Putnam Investments first reported a position in IMVT in Q2 2020 and has held it in 4 quarters since. The position peaked at $6.33M in Q4 2020. 228 funds tracked by Wall St. Rank hold IMVT as of Q4 2023.

  • Putnam Investments held 52,984 shares of Immunovant worth $2.23M as of Q4 2023.
  • Immunovant was a new Putnam Investments position in Q4 2023.
  • Immunovant made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #733 holding.
  • Putnam Investments first reported a position in Immunovant in Q2 2020 and has held it in 4 quarters since.
  • Putnam Investments's Immunovant position peaked at $6.33M in Q4 2020.
  • 228 funds tracked by Wall St. Rank held Immunovant as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.